Op-Ed | Environment & Health I Am One of 20 Million in US With Long COVID. RFK Pulled the Rug From Under Us. RFK Jr. has shut down the Office of Long COVID Research and Practice, gutted funding, and derailed trials and studies. By Jesse Hagopian , Truthout October 20, 2025 Truthout
News | Environment & Health A Drugmaker Failed to Fix Safety Violations. The FDA Repeatedly Let It Slide. "If your market [share] is big enough, then you get leeway,” one former inspector said. By Megan Rose & Debbie Cenziper , ProPublica August 12, 2025 Truthout
News | Environment & Health Commercialization Is Making Access to the New COVID Vaccine More Difficult As health care inequities deepen, pharmaceutical giants and insurers are maximizing profits. By Laura Weiss , Prism October 9, 2023 Truthout
News | Environment & Health All Manufacturers of 10 Drugs Set for Medicare Negotiation Agree to Participate The negotiation process won't begin until early 2024, and new prices won't be implemented until two years later. By Chris Walker , Truthout October 3, 2023 Truthout
News | Environment & Health Big Pharma Raked in $82B Last Year While Lobbying Against Drug Price Proposals The companies also upped their stock buyback and dividend payouts by nearly $7 billion last year. By Sharon Zhang , Truthout July 25, 2023 Truthout
News | Environment & Health Advocates Urge Schumer to “Put an End to Insulin Profiteering” in Health Package The groups are urging Schumer to ensure that patients across the board can afford insulin. By Sharon Zhang , Truthout July 11, 2023 Truthout
News | Environment & Health Sanders Will Block Health Nominees Until Biden Offers Plan to Lower Drug Prices As chair of the Senate HELP Committee, Sanders has the unilateral power to block health-related nominees. By Sharon Zhang , Truthout June 13, 2023 Truthout
News | Environment & Health Merck Sues Government, Saying Plan to Lower Medicare Drug Prices Is “Extortion” The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments. By Sharon Zhang , Truthout June 6, 2023 Truthout
News | Environment & Health FDA Still Struggles to Inspect Foreign Drug Manufacturers After COVID Delays A series of deaths linked to bacteria-tainted eyedrops produced overseas has raised alarm over a lag in FDA inspections. By Irena Hwang , ProPublica April 22, 2023 Truthout
News | Environment & Health Sanders Slams Biden for Rejecting Request to Lower Price of $190K Cancer Drug The administration rejected a request to lower the price of prostate cancer drug Xtandi this week. By Sharon Zhang , Truthout March 22, 2023 Truthout